Elikem – potency product | Buy in Ukraine with delivery

What is Elikem?

The drug ELIKEM belongs to the group of modern combination medicines used for the correction of functional disorders of the musculoskeletal system and for supporting metabolic processes in connective tissue. The manufacturer of the drug is the pharmaceutical company Elikem, which specializes in the development of products with proven bioavailability of active components. The release form is oral tablets, which provides a systemic effect on the body and convenience in daily use. The drug is dispensed in pharmacies upon a doctor's recommendation, as it requires a preliminary assessment of the clinical picture. Thanks to its balanced composition, ELIKEM can be used both as part of complex therapy and for long-term maintenance of remission in chronic processes.

The pharmacological action of ELIKEM is aimed at restoring the balance of trace elements and biologically active substances involved in the synthesis of collagen, elastin, and proteoglycans. These structural proteins are the foundation of cartilage tissue, ligaments, tendons, and skin; therefore, their deficiency quickly manifests as pain, stiffness, and reduced functional activity of the joints. The drug acts gradually, accumulating its effect in the tissues, which distinguishes it from symptomatic painkillers. Clinical observations demonstrate that regular intake of ELIKEM helps reduce the severity of inflammatory reactions and slow down degenerative changes in articular cartilage. This allows the drug to be considered a pathogenetically oriented agent, rather than merely temporary symptom relief.

It is important to understand that ELIKEM is not a dietary supplement, but belongs to the category of medicinal products with clearly defined indications and contraindications. Its effectiveness depends on adherence to the recommended dosage regimen and the duration of the course, which usually lasts several months. Self-medication can be dangerous, as joint pain can have various origins — from traumatic to infectious or autoimmune. Therefore, before starting ELIKEM, a consultation with a doctor is necessary to establish an accurate diagnosis and exclude conditions in which the drug is contraindicated. The body's individual response to the components of the product may vary, which also requires medical supervision at the initial stages of therapy.

What is Elikem prescribed for?

The main indications for prescribing ELIKEM are degenerative-dystrophic joint diseases, in particular osteoarthritis of various localizations — knee, hip, shoulder, and small joints of the hands. In these conditions, the drug helps to restore the shock-absorbing properties of cartilage, reduce friction of joint surfaces, and decrease the intensity of pain syndrome. Patients report improved mobility after the first few weeks of regular use, but a stable therapeutic effect forms gradually. ELIKEM is also prescribed during the rehabilitation period after joint injuries, sprains, and fractures, when the demand for structural components for connective tissue increases significantly. The drug helps accelerate regeneration and reduces the risk of contractures and post-traumatic osteoarthritis.

A separate category of patients who may be recommended ELIKEM includes individuals with increased physical load on the musculoskeletal system — athletes, manual laborers, and overweight people. In such cases, the drug is used for the prevention of premature wear of articular cartilage and to support the elasticity of the ligamentous apparatus. Also, ELIKEM can be included in the complex therapy of inflammatory joint diseases, such as reactive arthritis or rheumatoid arthritis, as an adjuvant agent that potentiates the action of basic anti-inflammatory drugs. Significantly, the decision on the appropriateness of such a combination is made exclusively by a physician, taking into account the activity of the inflammatory process and the patient's general condition.

In addition to joint pathology, ELIKEM finds application in conditions associated with impaired collagen synthesis in the body. This can manifest as brittle nails, hair loss, reduced skin turgor, and slow wound healing. The drug provides the body with the necessary substrates to restore these structures, making it useful in dermatological and cosmetological practice. At the same time, it should be emphasized that ELIKEM is not a universal cure for all musculoskeletal problems, and its prescription must be clinically justified. Unauthorized expansion of indications or replacing other medicines with it can lead to the progression of the underlying disease and the loss of precious time for effective treatment.

Composition and active components of Elikem

The composition of ELIKEM includes carefully selected active components, each performing a specific function in supporting connective tissue health. The central component is glucosamine sulfate — a natural amino sugar that is a key building block for the synthesis of glycosaminoglycans that form the matrix of cartilage tissue. Glucosamine stimulates chondrocytes to produce collagen and proteoglycans, and also possesses moderate anti-inflammatory activity, reducing the release of inflammatory mediators into the joint cavity. The second important component is chondroitin sulfate, which retains water in the cartilage, ensuring its elasticity and resistance to compression loads. Chondroitin also inhibits enzymes that destroy cartilage tissue, particularly metalloproteinases and elastase, thereby slowing down the degenerative process.

Excipients of ELIKEM include methylsulfonylmethane — an organic sulfur compound that participates in the formation of disulfide bonds in collagen and keratin molecules. Sulfur is an essential element for maintaining the strength of ligaments, tendons, and the joint capsule, and its deficiency is often accompanied by increased soft tissue trauma. In addition, the composition of the drug includes vitamin C as a cofactor for enzymes that catalyze the hydroxylation of proline and lysine — a step necessary for the formation of stable collagen. Vitamin C also acts as an antioxidant, protecting cartilage cells from oxidative stress occurring during chronic inflammation. Auxiliary substances, such as microcrystalline cellulose and magnesium stearate, ensure the stability of the tablet form and the uniform release of active components in the gastrointestinal tract.

The mechanism of action of ELIKEM is based on the synergistic combination of these components, allowing an effect on different stages of the pathological process simultaneously. Glucosamine and chondroitin act as substrates for cartilage matrix restoration, while methylsulfonylmethane and vitamin C create optimal conditions for their absorption and integration into metabolic pathways. This comprehensive approach provides a more pronounced clinical effect compared to monotherapy with individual components. Absorption of active substances occurs in the small intestine, after which they are distributed primarily in tissues with a high content of glycosaminoglycans — articular cartilage, synovial fluid, and skin. The half-life of the components ranges from several hours to a day, which justifies the need for regular intake of the drug to maintain a stable concentration in tissues.

Dosage of Elikem

The standard recommended dose of ELIKEM for adult patients is one tablet twice daily during or immediately after meals. This regimen ensures a uniform intake of active components throughout the day and minimizes the risk of gastric mucosal irritation. In the first two weeks of therapy, the doctor may recommend a gradual dose increase — from one tablet daily to the full therapeutic dose, allowing the body to adapt to the drug. The duration of a continuous course is usually three to six months, after which the effectiveness of therapy is evaluated and the decision on continuing is made. In chronic degenerative joint diseases, repeated courses two to three times a year with breaks are possible, the duration of which is determined by the doctor.

For patients with impaired renal or hepatic function, a dose adjustment of ELIKEM or an increase in the interval between doses may be required. This is due to the fact that the excretion of drug metabolites partly depends on the functional state of these organs, and their insufficiency can lead to the accumulation of active substances. Elderly individuals usually do not require special dose adjustment, but more careful monitoring of tolerability is recommended due to the possible presence of concomitant diseases. Children and adolescents under 18 years of age are not prescribed ELIKEM due to the lack of sufficient data on safety and efficacy in this age group. Exceeding the recommended dose does not lead to a proportional increase in the therapeutic effect, but increases the likelihood of adverse reactions.

It is important to maintain regularity in taking ELIKEM, as the therapeutic effect develops gradually and depends on the accumulation of active components in tissues. Missing a single dose is not critical, but you should not compensate for it by taking a double dose next time — this may cause adverse gastrointestinal reactions. If a patient forgot to take a tablet, it should be taken as soon as possible, provided there are more than six hours left until the next dose. In case of a significant delay, the missed dose is skipped, and the patient returns to the normal schedule. The duration of the course and the need for repeated treatment cycles are determined by the physician based on the dynamics of clinical symptoms, results of instrumental studies, and individual patient response to therapy.

How to take Elikem correctly?

ELIKEM tablets should be swallowed whole, without chewing or crushing, with a sufficient amount of water — at least 150–200 ml. Taking it during or immediately after a meal improves the absorption of fat-soluble components and reduces the likelihood of dyspeptic phenomena, such as nausea or a feeling of heaviness in the epigastrium. Dividing the daily dose into two takes — morning and evening — is optimal, as it allows maintaining a stable concentration of active substances in the blood and synovial fluid. Taking ELIKEM on an empty stomach is not recommended, especially for patients with chronic gastritis, gastroesophageal reflux disease, or a history of peptic ulcer. Following these simple rules significantly increases the tolerability of the drug and ensures the full implementation of its pharmacological potential.

During the treatment course with ELIKEM, it is recommended to maintain a balanced nutritional regime with an adequate content of protein, vitamins, and microelements, since connective tissue regeneration processes require complete building material. Moderate physical activity aimed at strengthening the muscle frame around affected joints is beneficial; however, excessive loads during flare-ups should be limited. Overweight patients are advised to gradually reduce weight, as every extra kilogram significantly increases mechanical load on joint surfaces. It is also important to maintain adequate hydration, as dehydration negatively affects the viscoelastic properties of synovial fluid and reduces therapy effectiveness. All these measures supplement drug treatment and do not replace it.

Special attention should be paid to situations where a patient takes ELIKEM simultaneously with other medications. The interval between taking the drug and antacids containing aluminum or magnesium should be at least two hours, as they may reduce the absorption of active components. Tetracycline antibiotics also require time separation when taking ELIKEM due to the risk of forming chelate complexes in the gastrointestinal tract. If a patient forgets to take a dose, they should not double the next one — this does not speed up the onset of effect, but increases the risk of side effects. Before starting therapy, the doctor must be informed of all medications the patient takes regularly or occasionally, including over-the-counter products and herbal remedies.

Side effects of Elikem

Most patients tolerate ELIKEM well, but in some cases, side effects may occur, the frequency and severity of which depend on individual sensitivity. Most commonly observed are dyspeptic phenomena: nausea, a feeling of heaviness in the epigastric region, flatulence, less frequently — diarrhea or constipation. These symptoms usually occur at the beginning of therapy, are mild or moderate in nature, and resolve spontaneously during the first few days of intake. To reduce their severity, it is recommended to take the drug with meals and not to exceed the prescribed dose. If dyspeptic manifestations persist for more than a week or worsen, you should consult a doctor to adjust therapeutic tactics.

Uncommon side effects of ELIKEM include allergic reactions in the form of skin rash, itching, hives, or redness of certain areas of the skin. In rare cases, angioedema may develop, accompanied by swelling of the face, lips, tongue, and difficulty breathing — this condition requires immediate discontinuation of the drug and emergency medical attention. From the nervous system, headaches, dizziness, or drowsiness are occasionally noted, which usually pass without additional intervention. Patients with diabetes mellitus should consider that glucosamine in the product may slightly affect blood glucose levels, so more frequent blood sugar monitoring is recommended at the start of therapy. An individual body reaction to components of ELIKEM may differ from those described, so any unusual symptoms should be discussed with a doctor.

Rare side effects of ELIKEM may include impaired liver function, manifested by increased transaminase levels in blood biochemistry tests, or transient increases in blood pressure. Such changes are usually reversible after discontinuation of the drug or dose reduction. Periodic laboratory monitoring is recommended during a long course of therapy for patients with chronic liver and kidney diseases. It is important to consult a doctor immediately if severe weakness, yellowing of the skin or sclera, dark urine, a significant loss of appetite, or unusual bleeding occur while taking ELIKEM. Timely reporting of side effects to a physician allows for quick adjustment of treatment and avoidance of serious complications, while maintaining the therapeutic benefit of the drug.

Contraindications of Elikem

Absolute contraindications to the use of ELIKEM are individual intolerance to any of the components of the drug, including active and auxiliary substances. A history of allergic reactions to glucosamine, chondroitin, or other ingredients is grounds for a complete refusal to prescribe it. The drug is not used in patients with severe renal impairment, as impaired excretion of metabolites can lead to their accumulation in the body and toxic effects. Also, ELIKEM is contraindicated in phenylketonuria — an inherited disorder of amino acid metabolism in which the body cannot metabolize phenylalanine, which may be part of the auxiliary components. Childhood age under 18 is a contraindication due to the lack of sufficient safety data in pediatric practice.

Relative contraindications in which prescribing ELIKEM requires special caution and medical supervision include diabetes mellitus, bronchial asthma, and chronic gastrointestinal diseases in the acute stage. For patients with bleeding disorders or those taking anticoagulants, the drug is prescribed with monitoring of coagulogram parameters, as chondroitin can potentiate the anticoagulant effect. During pregnancy and breastfeeding, the use of ELIKEM is not recommended, as safety studies for the fetus and infant have not been conducted. If a need for treatment arises during this period, the decision is made by a doctor after a thorough assessment of the ratio between potential benefits to the mother and possible risks to the child. The drug is prescribed to elderly patients in standard doses, but taking into account concomitant pathology and polypharmacy.

It should be emphasized separately that ELIKEM is not intended for the treatment of acute pain syndrome caused by trauma, infectious arthritis, or a gout attack. In such cases, the drug can be added to therapy only after stabilization of the acute condition and elimination of the active inflammatory process. Patients with a confirmed allergy to seafood should take glucosamine preparations with caution, as part of the raw materials for its production may be of marine origin. Before starting a course of ELIKEM, the doctor must take a full allergy history and assess the presence of concomitant diseases that may affect safety. Unauthorized use of the drug in the presence of contraindications can lead to serious complications, so consultation with a specialist is mandatory.

Interaction of Elikem with other drugs and alcohol

ELIKEM may interact with a number of medications, requiring a careful approach to combination therapy. The most clinically significant interaction is with anticoagulants — warfarin, acenocoumarol, and other blood thinners. Chondroitin in the composition of the drug can enhance their action, increasing the risk of bleeding; therefore, patients taking anticoagulants need regular monitoring of international normalized ratio (INR) parameters and adjustment of the anticoagulant dose as needed. Simultaneous administration of ELIKEM with tetracycline antibiotics can reduce the absorption of the latter in the gastrointestinal tract, so the interval between taking these drugs should be at least two to three hours. Antacids containing aluminum or magnesium are also capable of reducing the bioavailability of the active components of the drug.

Consuming alcohol during a course of ELIKEM is not recommended, as ethanol can increase the load on the liver and reduce the efficiency of regenerative processes in connective tissue. Alcohol promotes dehydration, which negatively affects the state of synovial fluid and slows down cartilage restoration. In addition, combining alcohol with any medicines increases the risk of unpredictable reactions from the gastrointestinal tract and central nervous system. ELIKEM does not directly affect the speed of psychomotor reactions, so driving vehicles and operating machinery during therapy are usually permitted. However, in case of dizziness or drowsiness as a side effect, one should refrain from such activities until the condition stabilizes.

Where to buy Elikem in Ukraine

The drug ELIKEM is available in pharmacy chains in Ukraine, as well as through certified online platforms that deliver medicines. Purchasing the drug requires a prescription from a doctor, as ELIKEM belongs to prescription medicines, and its uncontrolled use can be dangerous to health. The cost of the drug may vary depending on the pharmacy chain, region, and form of release, so patients are recommended to compare prices from different sources. Storage conditions for ELIKEM require a dry place, protected from light, at a temperature not exceeding 25 degrees Celsius, out of reach of children. The expiration date is indicated on the package, and the use of the drug after its expiration is strictly prohibited.

Before purchasing ELIKEM, it is important to ensure the authenticity of the product and the presence of appropriate labeling in the Ukrainian language. Online orders should be placed only through verified platforms licensed for retail sales of medicines to avoid the risk of receiving counterfeit products. Delivery of the drug is usually carried out by courier services or through postal operator branches, while it is important to observe transportation conditions that ensure the preservation of the medicine's quality. Patients are advised to keep the receipt and packaging throughout the course of treatment for potential inquiry to the manufacturer or regulatory authorities in case of quality issues. Always consult a doctor before starting ELIKEM and do not use the drug without a preliminary medical examination.